1. Home
  2. PHIO vs FMST Comparison

PHIO vs FMST Comparison

Compare PHIO & FMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHIO
  • FMST
  • Stock Information
  • Founded
  • PHIO 2011
  • FMST 2005
  • Country
  • PHIO United States
  • FMST Canada
  • Employees
  • PHIO N/A
  • FMST N/A
  • Industry
  • PHIO Biotechnology: Pharmaceutical Preparations
  • FMST Other Metals and Minerals
  • Sector
  • PHIO Health Care
  • FMST Basic Materials
  • Exchange
  • PHIO Nasdaq
  • FMST Nasdaq
  • Market Cap
  • PHIO 8.6M
  • FMST 7.1M
  • IPO Year
  • PHIO N/A
  • FMST N/A
  • Fundamental
  • Price
  • PHIO $2.16
  • FMST $3.27
  • Analyst Decision
  • PHIO Strong Buy
  • FMST
  • Analyst Count
  • PHIO 2
  • FMST 0
  • Target Price
  • PHIO $9.00
  • FMST N/A
  • AVG Volume (30 Days)
  • PHIO 703.0K
  • FMST 1.2M
  • Earning Date
  • PHIO 08-13-2025
  • FMST 01-01-0001
  • Dividend Yield
  • PHIO N/A
  • FMST N/A
  • EPS Growth
  • PHIO N/A
  • FMST N/A
  • EPS
  • PHIO N/A
  • FMST N/A
  • Revenue
  • PHIO N/A
  • FMST N/A
  • Revenue This Year
  • PHIO N/A
  • FMST N/A
  • Revenue Next Year
  • PHIO N/A
  • FMST N/A
  • P/E Ratio
  • PHIO N/A
  • FMST N/A
  • Revenue Growth
  • PHIO N/A
  • FMST N/A
  • 52 Week Low
  • PHIO $0.97
  • FMST $0.55
  • 52 Week High
  • PHIO $9.79
  • FMST $5.74
  • Technical
  • Relative Strength Index (RSI)
  • PHIO 50.19
  • FMST 56.55
  • Support Level
  • PHIO $2.11
  • FMST $3.27
  • Resistance Level
  • PHIO $2.30
  • FMST $3.78
  • Average True Range (ATR)
  • PHIO 0.21
  • FMST 0.53
  • MACD
  • PHIO -0.04
  • FMST -0.12
  • Stochastic Oscillator
  • PHIO 9.65
  • FMST 27.69

About PHIO Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.

About FMST Foremost Lithium Resource & Technology Ltd. Common stock

Foremost Clean Energy Ltd is an emerging North American uranium and lithium exploration company. Its uranium portfolio consists of projects at different stages of exploration from grassroots, to those with significant historical exploration and drill-ready targets. It also maintains a secondary portfolio of lithium projects at different stages of development spanning 50,000-plus acres across Manitoba and Quebec.

Share on Social Networks: